# Denis Glotz

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/denis-glotz/

## Facts

| Field | Value |
| --- | --- |
| Citations | 22,737 |
| Field | Renal Transplantation Outcomes and Treatments |
| h-index | 64 |
| i10-index | 171 |
| Last Known Institution | Inserm |
| OpenAlex ID | https://openalex.org/A5038248105 |
| ORCID iD | https://orcid.org/0000-0001-5258-4237 |
| Works | 329 |

## Researcher papers

- [Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions](https://scholariq.org/papers/banff-07-classification-of-renal-allograft-pathology-updates-and-future/)
- [Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions](https://scholariq.org/papers/banff-2013-meeting-report-inclusion-of-c4d-negative-antibody-mediated-rejection/)
- [Antibody-Mediated Rejection Criteria - an Addition to the Banff ’97 Classification of Renal Allograft Rejection](https://scholariq.org/papers/antibody-mediated-rejection-criteria-an-addition-to-the-banff-97-classification/)
- [The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials](https://scholariq.org/papers/the-banff-2017-kidney-meeting-report-revised-diagnostic-criteria-for-chronic/)
- [The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection](https://scholariq.org/papers/the-banff-2019-kidney-meeting-report-i-updates-on-and-clarification-of-criteria/)
- [The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology](https://scholariq.org/papers/the-banff-2015-kidney-meeting-report-current-challenges-in-rejection/)
- [Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data](https://scholariq.org/papers/effect-of-sirolimus-on-malignancy-and-survival-after-kidney-transplantation/)

## Researcher topics

- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Transplantation: Methods and Outcomes](https://scholariq.org/topics/transplantation-methods-and-outcomes-2/)
- [Organ Transplantation Techniques and Outcomes](https://scholariq.org/topics/organ-transplantation-techniques-and-outcomes/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)

## Researcher university

- [Inserm](https://scholariq.org/institutions/inserm/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.